Off-Patent Biologicals and Biosimilars Tendering in Europe—A Proposal towards More Sustainable Practices

Background: In Europe, off-patent biologicals and biosimilars are largely procured by means of tender procedures. The organization and design of tenders may play a key role in the evolving biosimilar market, and currently, it is not fully elucidated how tenders for off-patent biologicals and biosimi...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Liese Barbier, Steven Simoens, Caroline Soontjens, Barbara Claus, Arnold G. Vulto, Isabelle Huys
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-05-01
Edice:	Pharmaceuticals
Témata:	tender procurement off-patent biological biosimilar award criteria
On-line přístup:	https://www.mdpi.com/1424-8247/14/6/499
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!